$200,81
-$2,02(-0,99%)
*Data last updated: 2026-04-08 00:43 (UTC+8)
As of 2026-04-08 00:43, AstraZeneca (AZN) is priced at $200,81, with a total market cap of $155,65B, a P/E ratio of 13,26, and a dividend yield of 1,57%. Today, the stock price fluctuated between $196,99 and $202,00. The current price is 1,93% above the day's low and 0,58% below the day's high, with a trading volume of 2,36M. Over the past 52 weeks, AZN has traded between $66,16 to $212,72, and the current price is -5,59% away from the 52-week high.
AZN Key Stats
Yesterday's Close$202,83
Market Cap$155,65B
Volume2,36M
P/E Ratio13,26
Dividend Yield (TTM)1,57%
Dividend Amount$2,14
Diluted EPS (TTM)6,68
Net Income (FY)$10,25B
Revenue (FY)$58,73B
Earnings Date2026-05-05
EPS Estimate2,53
Revenue Estimate$14,74B
Shares Outstanding767,42M
Beta (1Y)0.275
Ex-Dividend Date2026-02-20
Dividend Payment Date2026-03-23
About AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
SectorHealthcare
IndustryDrug Manufacturers - General
CEOPascal Claude Roland Soriot
HeadquartersCambridge,None,GB
Official Websitehttps://www.astrazeneca.com
Employees (FY)2,02K
Average Revenue (1Y)$29,03M
Net Income per Employee$5,06M
AstraZeneca (AZN) FAQ
What's the stock price of AstraZeneca (AZN) today?
x
AstraZeneca (AZN) is currently trading at $200,81, with a 24h change of -0,99%. The 52-week trading range is $66,16–$212,72.
What are the 52-week high and low prices for AstraZeneca (AZN)?
x
What is the price-to-earnings (P/E) ratio of AstraZeneca (AZN)? What does it indicate?
x
What is the market cap of AstraZeneca (AZN)?
x
What is the most recent quarterly earnings per share (EPS) for AstraZeneca (AZN)?
x
Should you buy or sell AstraZeneca (AZN) now?
x
What factors can affect the stock price of AstraZeneca (AZN)?
x
How to buy AstraZeneca (AZN) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
